A 42-year-old female with IgA monoclonal gammopathy and Bence-Jones proteinuria suffered from recurrent episodes of Henoch-Schönlein syndrome and renal failure. The renal biopsy showed a diffuse proliferative ‘crescentic’ glomerulonephritis with mesangial IgA deposition. She responded to steroids but immunosuppressive therapy failed to prevent relapse. Since the introduction of cytotoxic therapy she has had no further relapse. Cytotoxic therapy may be beneficial in monoclonal gammopathy even in the absence of malignancy where the clinical syndrome is the result of the presence of a paraprotein.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.